BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24722054)

  • 21. Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture.
    Wang Y; Huso DL; Harrington J; Kellner J; Jeong DK; Turney J; McNiece IK
    Cytotherapy; 2005; 7(6):509-19. PubMed ID: 16306013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subset of CD45+/CD19 - cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma.
    Kim SM; Lee ST; Ryu KJ; Kim HJ; Kim SH; Ko YH; Kim WS; Kim SJ
    Leuk Lymphoma; 2015; 56(11):3052-7. PubMed ID: 25739938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.
    Würth R; Pattarozzi A; Gatti M; Bajetto A; Corsaro A; Parodi A; Sirito R; Massollo M; Marini C; Zona G; Fenoglio D; Sambuceti G; Filaci G; Daga A; Barbieri F; Florio T
    Cell Cycle; 2013 Jan; 12(1):145-56. PubMed ID: 23255107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells.
    Friel AM; Zhang L; Curley MD; Therrien VA; Sergent PA; Belden SE; Borger DR; Mohapatra G; Zukerberg LR; Foster R; Rueda BR
    Reprod Biol Endocrinol; 2010 Dec; 8():147. PubMed ID: 21122138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD133 is a marker for long-term repopulating murine epidermal stem cells.
    Charruyer A; Strachan LR; Yue L; Toth AS; Cecchini G; Mancianti ML; Ghadially R
    J Invest Dermatol; 2012 Nov; 132(11):2522-33. PubMed ID: 22763787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.
    Friedman S; Lu M; Schultz A; Thomas D; Lin RY
    PLoS One; 2009; 4(4):e5395. PubMed ID: 19404394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib and radioresistant glioblastoma-derived CD133+ cells: improvement in radiotherapeutic effects. Laboratory investigation.
    Ma HI; Chiou SH; Hueng DY; Tai LK; Huang PI; Kao CL; Chen YW; Sytwu HK
    J Neurosurg; 2011 Mar; 114(3):651-62. PubMed ID: 21054139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD133 induces tumour-initiating properties in HEK293 cells.
    Canis M; Lechner A; Mack B; Zengel P; Laubender RP; Koehler U; Heissmeyer V; Gires O
    Tumour Biol; 2013 Feb; 34(1):437-43. PubMed ID: 23150174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy.
    Ke CC; Liu RS; Yang AH; Liu CS; Chi CW; Tseng LM; Tsai YF; Ho JH; Lee CH; Lee OK
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):61-71. PubMed ID: 23081821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Embryonic retinal tumors in SV40 T-Ag transgenic mice contain CD133+ tumor-initiating cells.
    Wadhwa L; Bond WS; Perlaky L; Overbeek PA; Hurwitz MY; Chévez-Barrios P; Hurwitz RL
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3454-62. PubMed ID: 22562503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity.
    Shi CJ; Gao J; Wang M; Wang X; Tian R; Zhu F; Shen M; Qin RY
    World J Gastroenterol; 2011 Jun; 17(24):2965-71. PubMed ID: 21734809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
    Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
    Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.
    Bertolini G; Roz L; Perego P; Tortoreto M; Fontanella E; Gatti L; Pratesi G; Fabbri A; Andriani F; Tinelli S; Roz E; Caserini R; Lo Vullo S; Camerini T; Mariani L; Delia D; Calabrò E; Pastorino U; Sozzi G
    Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16281-6. PubMed ID: 19805294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells.
    Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C
    Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset.
    Kucerova L; Feketeova L; Kozovska Z; Poturnajova M; Matuskova M; Nencka R; Babal P
    Thyroid; 2014 Mar; 24(3):520-32. PubMed ID: 24073856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.